/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
-0.29%
Natural Gas
-0.64%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-0.29%
VIX
N/A
Economic Calendar
EUR/USD
-0.29%
Natural Gas
-0.64%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-0.29%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Fed Surprises With An Aggressive Rate Cut
about 7 hours ago
Crude Inventories Decline By 1.6 Million Barrels
about 8 hours ago
US Housing Starts Surge 9.6% in August as Lower Mortgage Rates Boost Builder Stocks
about 11 hours ago
UK Core Inflation Rises to 3.6% in August Sinking BoE Rate Cut Hopes
about 19 hours ago
NAHB Housing Market Index Rises To 41, Beating Analyst Expectations
1 day ago
US Retail Sales Rise 0.1% in August, Nonstore Retailers Up 7.8%, Fed Rate Cut Expected
1 day ago
Australian Dollar Forecast: AUD/USD Faces Key Test Amid Aussie and US Jobs Data
38 minutes ago
Japanese Yen Forecast: Will USD/JPY Break 139.5? BoJ and US Labor Market in Focus
about 2 hours ago
Fed Reduces Overnight Rate by 50 Basis Points
about 4 hours ago
Gold Price Forecast: Pulls Back After Hitting Record High Amid Fed Decision
about 4 hours ago
Natural Gas Price Forecast: Eyes 200-Day Support Amid Weak Close
about 4 hours ago
NASDAQ Index, SP500, Dow Jones Forecasts – SP500 Tests 5700 As Fed Cuts Rates By 50 Bps
about 7 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
PTGX
news
Protagonist Therapeutics Inc
Follow
PTGX
(
Nasdaq - US
)
Closed
44.70
-0.21 (-0.47%)
in
:
usd
•
As of: Sep 18, 2024 15:59
UTC -4
Open
45.19
High
46.32
Low
44.40
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
Latest News
Benzinga
Sep 10, 2024
Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines
PTGX
-0.47%
Zacks Investment Research
Aug 6, 2024
Protagonist Therapeutics (PTGX) Reports Q2 Loss, Misses Revenue Estimates
PTGX
-0.47%
Zacks Investment Research
Jul 18, 2024
Protagonist Therapeutics (PTGX) is on the Move, Here's Why the Trend Could be Sustainable
PTGX
-0.47%
InvestorPlace
Jul 11, 2024
3 Growth Stocks No One Is Watching (But They Should Be)
PTGX
-0.47%
Investors Business Daily
Jun 28, 2024
Protagonist Therapeutics Surges On Plans To Join S&P SmallCap 600
PTGX
-0.47%
InvestorPlace
Jun 5, 2024
The 3 Best Biotech Stocks to Buy in June 2024
BBIO
-2.84%
Zacks Investment Research
Apr 5, 2024
All You Need to Know About Protagonist Therapeutics (PTGX) Rating Upgrade to Buy
Zacks Investment Research
Mar 18, 2024
Wall Street Analysts Think Protagonist Therapeutics (PTGX) Could Surge 48.38%: Read This Before Placing a Bet
Zacks Investment Research
Mar 15, 2024
4 Stocks to Buy for Attractive Earnings Acceleration
Zacks Investment Research
Mar 4, 2024
4 Must-Buy Stocks for Remarkable Earnings Acceleration
Zacks Investment Research
Mar 1, 2024
Earnings Estimates Moving Higher for Protagonist Therapeutics (PTGX): Time to Buy?
Zacks Investment Research
Mar 1, 2024
Are You Looking for a Top Momentum Pick? Why Protagonist Therapeutics (PTGX) is a Great Choice
Zacks Investment Research
Mar 1, 2024
Protagonist Therapeutics (PTGX) Upgraded to Buy: What Does It Mean for the Stock?
Zacks Investment Research
Mar 1, 2024
Wall Street Analysts Believe Protagonist Therapeutics (PTGX) Could Rally 37.16%: Here's is How to Trade
Zacks Investment Research
Mar 1, 2024
Recent Price Trend in Protagonist Therapeutics (PTGX) is Your Friend, Here's Why
Zacks Investment Research
Feb 2, 2024
Protagonist (PTGX) Up 14% on Licensing Deal With Takeda
Seeking Alpha
Dec 8, 2023
Protagonist Therapeutics: On A Ship That Could Be About To Sail
Zacks Investment Research
Nov 9, 2023
Does Protagonist Therapeutics (PTGX) Have the Potential to Rally 141.08% as Wall Street Analysts Expect?
Seeking Alpha
Sep 22, 2023
Protagonist Therapeutics: There Are Reasons Behind Johnson & Johnson's Optimism
Seeking Alpha
Sep 4, 2023
Protagonist Therapeutics: Evaluating Rusfertide's Potential For PV
Stocks
Popular
Currencies
Commodities
Indices
Stocks
ETFs
Crypto
Watchlist
Loading
Loading
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker